Liquid chromatographic control of the identity, purity and “potency” of biomolecules used as drugs
✍ Scribed by N.A. Farid; L.M. Atkins; G.W. Becker; A. Dinner; R.E. Heiney; D.J. Miner; R.M. Riggin
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 277 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0731-7085
No coin nor oath required. For personal study only.
✦ Synopsis
The use of high-performance liquid chromatography (HPLC) in the control of rDNA-derived human insulin and human growth hormone is described. Powerful identity tests based upon reversed-phase HPLC separation of enzymatic digests have been developed. Size exclusion and reversed-phase assays are used to control higher molecular weight materials and monomeric derivatives, respectively, for both proteins. Finally, HPLC is used to control the relevant protein content, which in concert with other information controls the biopotency of the protein preparations.
📜 SIMILAR VOLUMES
A glycopeptide antibiotic (teicoplanin) bonded stationary phase was employed for liquid chromatographic enantioseparation of dopa, ␣-methyldopa, carbidopa, and several other structurally related compounds. The influence of mobile phase composition in both reversed-phase and polar organic modes was i
The simultaneous separation of the N-dimethylcarbamate pirimicarb and its metabolites V-VII was carried out by liquid chromatography (LC) using diode array detection (DAD). 'Dvo cohu~s, a 250 x 4.6 mm i.d. column packed with S-pm particles with a cyanopropyl modified silica stationary phase and a 15